Medicinal Cannabis Matters – Friday Roundup 29th November.
Medicinal Cannabis Matters | Friday roundup 29th November 2024.
Medicinal Cannabis Matters – Our weekly round-up of what has been happening in the world of medicinal cannabis this week.
Medicann announces acquisition of Integro IOM
This week, here at Medicann we announced that we acquired Integro IOM and announced Dr Sunny Nayee as our local on-island prescribing expert. The acquisition enables patients of Medicann IOM to access an on-island service, removing the need for patients to have virtual consultations with UK clinics. An exclusive partnership with 420 PHARMA, also means that patients can enjoy next-day dispensing with a flat rate £20 dispensing fee.
How the body’s own cannabinoids may influence the symptoms and treatment of ADHD.
The Human body produces its own cannabinoids – the endocannabinoid system which leads to researchers wondering how this system might influence ADHD. The research is published in the journal Development Psychobiology.
The role of medicinal cannabis in managing arthritis symptoms.
Research has shown promise in medicinal cannabis in managing arthritis symptoms, and as public and scientific interest in medicinal cannabis continues to grow, so does the potential for more robust research into its effects on arthritis and similar conditions.
If you’re interested in learning more about medicinal cannabis and how it can help you manage your condition, fill out the simple form linked below. Start your journey today with the only award-winning clinic in Jersey and Guernsey.
Check your eligibility.
https://www.medicann.co.uk/book-consultation/eligibility
Disclaimer:
This blog post and the following featured articles are for information only and any articles on external platforms may be amended at any time. Articles that we refer to in our weekly roundup do not reflect the views of Medicann.
